US Patent Issued to Novartis on Aug. 12 for "Methods of treating Sjogren's syndrome using a Bruton's tyrosine kinase inhibitor" (Swiss, American, French, German Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,556, issued on Aug. 12, was assigned to Novartis AG (Basel, Switzerland).

"Methods of treating Sjogren's syndrome using a Bruton's tyrosine kinase inhibitor" was invented by Souvik Bhattacharya (Weymouth, Mass.), Bruno Bieth (Saint-Louis, France), Maciej Cabanski (Allschwil, Switzerland), Bruno Cenni (Sissach, Switzerland), Stefan De Buck (Buesserach, Switzerland), Martin Kaul (Neustadt, Germany), Arvind Kinhikar (Cambridge, Mass.), Andrijana Radivojevic (New York) and Alessandra Vitaliti Garami (Oberwil, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods for treating Sjogren's Syndrome disease using...